Research Topic: Therapeutic targets

Fungal Metabolomics: A Comprehensive Approach to Understanding Pathogenesis in Humans and Identifying Potential Therapeutics

mycolabadmin

This review explains how scientists use metabolomics—a technique that identifies all chemical compounds in organisms—to understand how fungi cause disease and resist medicines. Fungi produce many different chemicals that help them attack our bodies and survive treatments, but these same chemicals could also be used to create new medicines. By studying these fungal chemicals, researchers can develop better antifungal drugs and understand how fungi manage to evade our immune system.

Read More »

The P-type calcium pump Spf1 regulates immune response by maintenance of the endoplasmic reticulum-plasma membrane contacts during Candida albicans systemic infection

mycolabadmin

A fungal pump protein called Spf1 helps Candida albicans secrete toxins that damage the immune system during infection. When researchers deleted the SPF1 gene, the fungus could not effectively release these toxins, triggering a much weaker immune response and allowing infected mice to survive better. This discovery suggests that controlling this calcium pump could be a new strategy for treating serious fungal infections.

Read More »

The cyclase-associated protein contributes to antifungal susceptibility and virulence in Aspergillus fumigatus

mycolabadmin

Researchers found that removing a specific protein called CAP from a dangerous mold called Aspergillus fumigatus makes it much weaker and easier to kill with antifungal drugs. This mold normally causes serious lung infections in people with weak immune systems. The study showed that CAP helps the mold grow and resist medicines, and blocking it could be a new way to treat these dangerous infections.

Read More »
Scroll to Top